97 related articles for article (PubMed ID: 17693190)
1. Altered transforming growth factor-beta pathway expression pattern in rat endometrial cancer.
Karlsson S; Holmberg E; Askerlund A; Levan KK
Cancer Genet Cytogenet; 2007 Aug; 177(1):43-50. PubMed ID: 17693190
[TBL] [Abstract][Full Text] [Related]
2. Expression analysis of human endometrial adenocarcinoma in an inbred rat model.
Karlsson S; Klinga-Levan K
Adv Exp Med Biol; 2008; 617():503-9. PubMed ID: 18497075
[TBL] [Abstract][Full Text] [Related]
3. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
[TBL] [Abstract][Full Text] [Related]
4. Identification of molecular markers and signaling pathway in endometrial cancer in Hong Kong Chinese women by genome-wide gene expression profiling.
Wong YF; Cheung TH; Lo KW; Yim SF; Siu NS; Chan SC; Ho TW; Wong KW; Yu MY; Wang VW; Li C; Gardner GJ; Bonome T; Johnson WB; Smith DI; Chung TK; Birrer MJ
Oncogene; 2007 Mar; 26(13):1971-82. PubMed ID: 17043662
[TBL] [Abstract][Full Text] [Related]
5. Aberrant expression and mutations of TGF-beta receptor type II gene in endometrial cancer.
Sakaguchi J; Kyo S; Kanaya T; Maida Y; Hashimoto M; Nakamura M; Yamada K; Inoue M
Gynecol Oncol; 2005 Sep; 98(3):427-33. PubMed ID: 15993480
[TBL] [Abstract][Full Text] [Related]
6. Concordant epigenetic silencing of transforming growth factor-beta signaling pathway genes occurs early in breast carcinogenesis.
Hinshelwood RA; Huschtscha LI; Melki J; Stirzaker C; Abdipranoto A; Vissel B; Ravasi T; Wells CA; Hume DA; Reddel RR; Clark SJ
Cancer Res; 2007 Dec; 67(24):11517-27. PubMed ID: 18089780
[TBL] [Abstract][Full Text] [Related]
7. Activin A inhibits growth-inhibitory signals by TGF-beta1 in differentiated human endometrial adenocarcinoma cells.
Tanaka T; Toujima S; Umesaki N
Oncol Rep; 2004 Apr; 11(4):875-9. PubMed ID: 15010888
[TBL] [Abstract][Full Text] [Related]
8. Genetic analysis of susceptibility to endometrial adenocarcinoma in the BDII rat model.
Roshani L; Mallon P; Sjostrand E; Wedekind D; Szpirer J; Szpirer C; Hedrich HJ; Klinga-Levan K
Cancer Genet Cytogenet; 2005 Apr; 158(2):137-41. PubMed ID: 15796960
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of cyclooxygenase-2 (COX-2) in the mouse urinary bladder induces the expression of immune- and cell proliferation-related genes.
Wang X; Colby JK; Rengel RC; Fischer SM; Clinton SK; Klein RD
Mol Carcinog; 2009 Jan; 48(1):1-13. PubMed ID: 18444251
[TBL] [Abstract][Full Text] [Related]
10. The impact of the genetic background on the genome make-up of tumor cells.
Falck E; Behboudi A; Klinga-Levan K
Genes Chromosomes Cancer; 2012 May; 51(5):438-46. PubMed ID: 22250046
[TBL] [Abstract][Full Text] [Related]
11. Altered gene expression profile in mouse bladder cancers induced by hydroxybutyl(butyl)nitrosamine.
Yao R; Lemon WJ; Wang Y; Grubbs CJ; Lubet RA; You M
Neoplasia; 2004; 6(5):569-77. PubMed ID: 15548366
[TBL] [Abstract][Full Text] [Related]
12. Sympathectomy suppresses tumor growth and alters gene-expression profiles in rat tongue cancer.
Raju B; Hultström M; Haug SR; Ibrahim SO; Heyeraas KJ
Eur J Oral Sci; 2009 Aug; 117(4):351-61. PubMed ID: 19627344
[TBL] [Abstract][Full Text] [Related]
13. Expression of tenascin-C by human endometrial adenocarcinoma and stroma cells: heterogeneity of splice variants and induction by TGF-beta.
Vollmer G; Tan MI; Wünsche W; Frank K
Biochem Cell Biol; 1997; 75(6):759-69. PubMed ID: 9599665
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of BMP7 in human colorectal cancer.
Motoyama K; Tanaka F; Kosaka Y; Mimori K; Uetake H; Inoue H; Sugihara K; Mori M
Ann Surg Oncol; 2008 May; 15(5):1530-7. PubMed ID: 18259822
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiling of oral submucous fibrosis using oligonucleotide microarray.
Hu Y; Jian X; Peng J; Jiang X; Li N; Zhou S
Oncol Rep; 2008 Aug; 20(2):287-94. PubMed ID: 18636188
[TBL] [Abstract][Full Text] [Related]
16. FGF2 transcript levels are positively correlated with EGF and IGF-1 in the malignant endometrium.
Soufla G; Sifakis S; Spandidos DA
Cancer Lett; 2008 Feb; 259(2):146-55. PubMed ID: 18006148
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta, estrogen, and progesterone converge on the regulation of p27Kip1 in the normal and malignant endometrium.
Lecanda J; Parekh TV; Gama P; Lin K; Liarski V; Uretsky S; Mittal K; Gold LI
Cancer Res; 2007 Feb; 67(3):1007-18. PubMed ID: 17283133
[TBL] [Abstract][Full Text] [Related]
18. Molecular profiling of bladder cancer: involvement of the TGF-beta pathway in bladder cancer progression.
Hung TT; Wang H; Kingsley EA; Risbridger GP; Russell PJ
Cancer Lett; 2008 Jun; 265(1):27-38. PubMed ID: 18477502
[TBL] [Abstract][Full Text] [Related]
19. Molecular profiling related to poor prognosis in thyroid carcinoma. Combining gene expression data and biological information.
Montero-Conde C; Martín-Campos JM; Lerma E; Gimenez G; Martínez-Guitarte JL; Combalía N; Montaner D; Matías-Guiu X; Dopazo J; de Leiva A; Robledo M; Mauricio D
Oncogene; 2008 Mar; 27(11):1554-61. PubMed ID: 17873908
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor beta isoforms (TGF-beta1, TGF-beta2, TGF-beta3) messenger RNA expression in laryngeal cancer.
Kapral M; Strzalka B; Kowalczyk M; Jurzak M; Mazurek U; Gierek T; Paluch J; Markowski J; Swiatkowska L; Weglarz L
Am J Otolaryngol; 2008; 29(4):233-7. PubMed ID: 18598833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]